Richard Klein News
Most Popular Richard Klein Story
Omeros prices IPO as it fends off ex-CFO's accusations
Seattle-based Omeros has priced its initial public offering of 6.8 million shares at $10 each, at the bottom of the $10 to $12 range it had originally expected. The tiny biotech has helped spur Read more...
Latest Headlines
- October 8, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
